CerviScan, an innovative digital microscope, a telemedicine platform and a cloud storage platform
Main beneficiary country:Cameroon
Country of origin: Cameroon
Healthcare themes targeted
Stage of development:
Area where initiative is utilised
Initiative start date
Our project targets breast and cervical cancers which are the leading causes of cancer related morbidity and mortality in sub-Saharan Africa where they accounted for 45.4% of new cases of cancers among women in 2012 In Cameroon, the contribution of breast and cervical cancers to the national burden of cancer is very high since more than four decades. According to the International Agency for Research on Cancer, Breast Cancer has the highest incidence among Cameroonian women with an Age- Standardized Ratio of 2,625 new cases per 100,000 women per year, thus accounting for 31.5% of all cancers in women. Cancer of the cervix ranks second among Cameroonian women with an Age- Standardized Ratio of 1,993 new cases per 100,000 women per year, representing 23.9% of all new cases of cancers in women. Close to 95% of patients with cancer in Cameroon are diagnosed with late- to end-stage disease, when treatment options are few and prognosis is poor. Screening techniques such as Mammography are centralised making them almost inaccessible for the rural, peri-urban and some of the Urban population; and it’s cost can prove to be a huge barrier to its accessibility for the rural population especially Pathological diagnosis is also a big burden in our context owing to the Limited number of Pathologists and Pathology Laboratories, with only 5 laboratories present nationally.
- This project permits a secure electronic record and storage of patient infomation and medical history. - Our simple and efficient Telemedicine platform permits healthcare providers in rural settings to share patient information and images, interact and discuss with higher level specialists in urban areas, which is very helpful in upgrading knowledge and skills of personnel in rural areas. - It equally enables remote diagnosis for patients in remote areas by specialists in urban areas for breast and cervical cancer in real time. These specialists who are only currently available in urban cities, far from the rural population. - It equally guarantees secure channel for referring patients and patient tracking in real time using mobile technology, therefore reinforcing the currently weak patient referral and tracking system. - Enables gathering of reliable data for future assessment for public health utility, planning and policy drafting, data which was previously unreliable and absent in most cases. - The platform is very valuable to share data and get second opinions in difficult cases, especially for pathological diagnosis. - Its valuable role for educational purposes cannot be underestimated where digital files could easily be accessed to better train medical nurses, medical students, doctors and residents. - This innovation is very beneficial in reducing time normally needed for samples to be received and analyzed by pathologists. The time and cost burden incurred when samples have to be collected, conserved and forwarded to other towns for pathologists to analyze is completely cut off.
Health professional training - Telemedicine (remote diagnosis and consultations) - Patient monitoring and medical data
14000 Number of beneficiaries since launch
200 Number of users per Month